Denver, CO (PRWEB) June 01, 2016
In honor of PTSD Awareness Month, CereScan, the nation’s leader in providing statistically measured brain diagnostics, is proud to assist veterans and service members struggling with post-traumatic stress by offering discounted brain diagnostic packages to military patients and their families.
During the month of June, CereScan will provide a 10% discount–up to a $560 value–on its comprehensive portfolio of brain diagnostic packages to military service members and their families. The promotion includes qSPECT (Quantitative Single Photon Emission Computed Tomography) brain imaging; psychiatric assessments; qEEG (Quantitative Electroencephalography) brain mapping; comprehensive SPECT findings report and review.
“Our team is committed and passionate about supporting military men and women, and the discounts being offered are further evidence of CereScan’s desire to make functional brain imaging affordable, and therefore available, to the service members and their families who need it,” said John Kelley, CEO of CereScan. “Providing hope and clarity to the women and men fighting PTSD and other invisible war wounds is a top priority.”
As the nation’s leader in functional brain imaging, CereScan has been on the front lines in the accurate identification of post-traumatic stress and traumatic brain injuries (TBI)– two of the most common injuries soldiers bring home. With overlapping symptoms, the two brain conditions are often confused with one another, yet their treatments are vastly different. TBI and PTSD affect the way the brain functions differently and CereScan’s qSPECT technology can detect and differentiate between the two disorders.
“My wife and I were able to finally see how my “invisible” wounds were impairing how my brain was functioning, and how these functional impairments were affecting my behavior and the symptoms I was struggling with,” said Ret. Major and CereScan patient Ben Richards. “Before CereScan, I was nearing the end of my road. They gave me the opportunity to build my own narrative and move forward.”
The U.S. Department of Veterans Affairs estimates that about 11 to 20% of veterans who served in the Iraq and Afghanistan conflicts have PTSD in a given year. Since 2000, 239,174 veterans who sought VA healthcare were diagnosed with PTSD, compared to 50,409 soldiers who were physically wounded in action.
CereScan’s qSPECT imaging technology goes beyond traditional diagnostic tools to review cerebral blood flow and cellular processes to assist active duty and veterans with the first step on their road to recovery, the correct diagnosis. By looking at how the brain functions, CereScan can accurately pinpoint brain abnormalities, helping physicians and patients create a targeted treatment plan.
In April 2016, CereScan and its wholly-owned subsidiary, Molecular Imaging of Colorado, began accepting TRICARE, the health insurance provider of the United States Department of Defense Military Health System. The insurance provides healthcare benefits, including reimbursements for functional brain imaging, to active-duty military members, retirees, and their families.
CereScan is the nation’s leader in providing statistically measured brain diagnostics based on a new generation of imaging software, PET/CT (Positron Emission Tomography/Computed Tomography) and SPECT (Single Photon Emission Computed Tomography) neuroimaging technologies. Referring and treating medical experts can rely on CereScan to offer differentiated diagnoses on a wide array of brain-based disorders including:
- Alzheimer’s Disease
- Anxiety Disorder
- Bipolar Disorder
- Mild Cognitive Impairment
- Obsessive Compulsive Disorder
- Parkinson’s Disease
- Traumatic Brain Injury
- Toxic Brain Injury
CereScan combines state-of-the-art SPECT and PET/CT brain imaging technologies with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the neurological basis of their conditions. In a variety of legal settings, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.CereScan.com.